LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Lista de Ações・Charles River Laboratories International Inc

Charles River Laboratories International Inc

Fechado

SetorSaúde

160.23 0.91

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

159.54

Máximo

161.2

Indicadores-chave
By Trading Economics
Rendimento	262M -15M
Vendas	1.6M 996M
EPS	2.06
Margem de lucro	-1.486
Funcionários	18,300
EBITDA	-11M 187M

Recomendações
By TipRanks
Recomendações	Comprar
Previsão para 12 meses	+28.12% upside

Dividendos
By Dow Jones
Próximos Ganhos	5 de ago. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-1.3B 7.2B
Abertura anterior	159.32
Fecho anterior	160.23

Sentimento de Notícias

By Acuity

50%

151 / 345 Ranking em Healthcare

Charles River Laboratories International Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

24 de mai. de 2026, 23:46 UTC

Conversa de Mercado

Pullback in Oil Prices Could Temper Inflation Expectations -- Market Talk

24 de mai. de 2026, 23:45 UTC

Conversa de Mercado

Gold, Silver Rise on Hopes for U.S.-Iran Deal -- Market Talk

24 de mai. de 2026, 23:42 UTC

Conversa de Mercado

Mineral Resources Bull More Positive Post Site Visit -- Market Talk

24 de mai. de 2026, 23:34 UTC

Conversa de Mercado

Oil Falls Amid Prospects for Reopening of Strait of Hormuz -- Market Talk

24 de mai. de 2026, 23:11 UTC

Conversa de Mercado

RBNZ Likely to Stand Pat But Watch for Dissent -- Market Talk

24 de mai. de 2026, 22:26 UTC

Aquisições, Fusões, Aquisições de Empresas

Beach Energy: La Bella 2 Will No Longer Be Drilled as Part of Equinox Campaign

24 de mai. de 2026, 22:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Beach Energy: Implied Transaction Value of Around A$130 Million After Tax

24 de mai. de 2026, 22:25 UTC

Aquisições, Fusões, Aquisições de Empresas

Beach Energy: Royalty Payments Likely to Total Around A$140 Million Based on Resource Booking

24 de mai. de 2026, 22:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Beach Energy to Get Production Royalty of A$3.75/GJ in Deal

24 de mai. de 2026, 22:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Beach Energy to Get A$70 Million Cash Proceeds When Deal Completes

24 de mai. de 2026, 22:23 UTC

Aquisições, Fusões, Aquisições de Empresas

Beach Energy Says Deal Includes Artisan Natural-Gas Discovery

24 de mai. de 2026, 22:23 UTC

Aquisições, Fusões, Aquisições de Empresas

Beach Energy Sells 60% Operated Interest in VIC/L35 Block in Otway Basin

24 de mai. de 2026, 22:11 UTC

Conversa de Mercado

Oil Price Unlikely to Return to Pre-Conflict Levels This Year -- Market Talk

24 de mai. de 2026, 22:04 UTC

Conversa de Mercado

Oil Price Likely Lower, Equities Higher on Iran Deal Talks Progress -- Market Talk

23 de mai. de 2026, 08:20 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

23 de mai. de 2026, 08:20 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

22 de mai. de 2026, 21:10 UTC

Ganhos

These Stocks Are Today's Movers: Dell, Apple, IBM, Estée Lauder, Futu, Rocket Lab, Workday, and More -- Barrons.com

22 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

22 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Aquisições, Fusões, Aquisições de Empresas

Financial Services Roundup: Market Talk

22 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Auto & Transport Roundup: Market Talk

22 de mai. de 2026, 20:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

22 de mai. de 2026, 19:47 UTC

Ganhos

Nvidia Has a Plan to Get the Stock Moving Again -- Barrons.com

22 de mai. de 2026, 19:17 UTC

Conversa de Mercado

U.S. Natural Gas Retreats As Weather Outlook Cools -- Market Talk

22 de mai. de 2026, 19:10 UTC

Conversa de Mercado

Oil Futures Edge Up Ahead of U.S. Long Weekend -- Market Talk

22 de mai. de 2026, 18:54 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

22 de mai. de 2026, 18:54 UTC

Conversa de Mercado

Kroger Seen Narrowing Pricing Gap Versus Walmart -- Market Talk

22 de mai. de 2026, 18:38 UTC

Conversa de Mercado

Canada's Population Slowdown Hits Demand for Consumer Companies -- Market Talk

22 de mai. de 2026, 18:35 UTC

Aquisições, Fusões, Aquisições de Empresas

IMAX Might Be Exploring a Sale. Who Could Be Buying. -- Barrons.com

22 de mai. de 2026, 18:09 UTC

Conversa de Mercado

Centralized Crypto Lending Slows in 1Q -- Market Talk

22 de mai. de 2026, 17:58 UTC

Conversa de Mercado

U.S. Oil Rig Count Shows Signs of Picking Up -- Market Talk

Comparação entre Pares

Variação de preço

Charles River Laboratories International Inc Previsão

Preço-alvo

By TipRanks

28.12% parte superior

Previsão para 12 meses

Média 205.38 USD 28.12%

Máximo 235 USD

Mínimo 160 USD

Com base em 10 analistas de Wall Street que oferecem metas de preço de 12 meses para Charles River Laboratories International Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

10 ratings

Comprar

Manter

Vender

Com base em 10 analistas que deram avaliações de ações para Charles River Laboratories International Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

151 / 345 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Charles River Laboratories International Inc

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.